KKR : Gamma Biosciences Announces Sale of Mirus Bio to Merck for $600 Million
MENLO PARK, Calif. and MADISON, Wis., May 23, 2024 - Gamma Biosciences, a life sciences platform established by KKR to address the advanced therapy bioprocessing market, today announced that it...
Source: marketscreener.com